Conditions: Rhinitis, Allergic, Perennial
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 474
Healthy volunteers: no

Brief summary:
The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of perennial allergic rhinitis.

Detailed description:

Arms:
arm 1: During the 6-week double-blind Treatment Period participants self-administered 4 actuations (two per nostril) of 80 µg BDP HFA once daily. arm 2: During the 6-week double-blind Treatment Period participants self-administered four actuations (two per nostril) of placebo HFA once daily.

Interventions: intervention 1: Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol intervention 2: Placebo Nasal Aerosol
Intervention descriptions: intervention 1: Beclomethasone dipropionate (BDP) Hydrofluoroalkane (HFA) Nasal Aerosol intervention 2: HFA Vehicle Aerosol

Protocol document: